These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17635520)

  • 1. Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines.
    Montanaro L; Mazzini G; Barbieri S; Vici M; Nardi-Pantoli A; Govoni M; Donati G; Treré D; Derenzini M
    Cell Prolif; 2007 Aug; 40(4):532-49. PubMed ID: 17635520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate.
    Scala F; Brighenti E; Govoni M; Imbrogno E; Fornari F; Treré D; Montanaro L; Derenzini M
    Oncogene; 2016 Feb; 35(8):977-89. PubMed ID: 25961931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).
    Pereira BP; Zhou Y; Gupta A; Leong DT; Aung KZ; Ling L; Pho RW; Galindo M; Salto-Tellez M; Stein GS; Cool SM; van Wijnen AJ; Nathan SS
    J Cell Physiol; 2009 Dec; 221(3):778-88. PubMed ID: 19746444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition.
    Pestov DG; Strezoska Z; Lau LF
    Mol Cell Biol; 2001 Jul; 21(13):4246-55. PubMed ID: 11390653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
    Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
    J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
    Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
    J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
    Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
    Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle arrest and apoptosis induced by aspidin PB through the p53/p21 and mitochondria-dependent pathways in human osteosarcoma cells.
    Wan D; Jiang C; Hua X; Wang T; Chai Y
    Anticancer Drugs; 2015 Oct; 26(9):931-41. PubMed ID: 26181229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
    Turi Z; Senkyrikova M; Mistrik M; Bartek J; Moudry P
    Cell Cycle; 2018; 17(1):92-101. PubMed ID: 29143558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells.
    Dong Z; Zhu C; Zhan Q; Jiang W
    Oncotarget; 2017 Feb; 8(8):13240-13252. PubMed ID: 28099941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation.
    Xu J; Yao Q; Hou Y; Xu M; Liu S; Yang L; Zhang L; Xu H
    Biomed Pharmacother; 2013 Jun; 67(5):381-6. PubMed ID: 23601845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells.
    Derenzini M; Montanaro L; Chillà A; Tosti E; Vici M; Barbieri S; Govoni M; Mazzini G; Treré D
    J Cell Physiol; 2005 Feb; 202(2):483-91. PubMed ID: 15389582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS].
    Xie XK; Yang DS; Ye ZM; Tao HM
    Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53.
    Li H; Han X; Yang S; Wang Y; Dong Y; Tang T
    Oncogene; 2021 Apr; 40(15):2785-2802. PubMed ID: 33716296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation.
    Donati G; Brighenti E; Vici M; Mazzini G; Treré D; Montanaro L; Derenzini M
    J Cell Sci; 2011 Sep; 124(Pt 17):3017-28. PubMed ID: 21878508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell.
    Wang JY; Chen CM; Chen CF; Wu PK; Chen WM
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition.
    Dai MS; Zeng SX; Jin Y; Sun XX; David L; Lu H
    Mol Cell Biol; 2004 Sep; 24(17):7654-68. PubMed ID: 15314173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
    Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
    Brighenti E; Treré D; Derenzini M
    Oncotarget; 2015 Nov; 6(36):38617-27. PubMed ID: 26415219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells.
    Benassi MS; Chiechi A; Ponticelli F; Pazzaglia L; Gamberi G; Zanella L; Manara MC; Perego P; Ferrari S; Picci P
    Cancer Lett; 2007 Jun; 250(2):194-205. PubMed ID: 17113707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.